New Genetic Markers For 'Chemobrain', Cognitive Impairment Associated With Cancer Treatment
Scholars recently characterized plasma levels of the biomarker dehydroepiandrosterone (DHEA) and its sulfated form (DHEAS) – jointly referred to as DHEA(S) – to be biological determinants of…